Treatment > Busulfan


Medulloblastoma


Antonio Pérez-Martínez, Alvaro Lassaletta, Marta González-Vicent, Julián Sevilla, Miguel Angel Díaz and Luis Madero
High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors
Journal of Neuro-Oncology, 71(1): 33-38, January 2005. (Abstract+)

Antonio Pérez-Martínez, Victor Quintero, Marta González Vicent, Julián Sevilla, Miguel Ángel Díaz and Luis Madero
High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors
J Neurooncol. 2004 Mar-Apr;67(1-2):101-6. (Abstract+)


Neoplastic Meningitis


S. Gururangan, H. S. Friedman, P. C. Phillips, W. Petros, S. M. Blaney, D. Hunt, L. E. Kun
Phase I study of intrathecal (i.t) Spartaject busulfan (Bu) in children with neoplastic meningitis (NM): A Pediatric Brain Tumor Consortium Trial
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 456

Jennifer A Quinn, Michael Glantz, William Petros, Jeremy Rich, Howard Sands, Sandra Tourt-Uhlig, Amy Walker, David Reardon, Sridharan Gururangan, John Sampson, Allan Friedman, O. M Colvin, Henry Friedman
Phase I trial of intrathecal Spartaject busulfan for patients with neoplastic meningitis
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No. 318

 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP